The Journal of BIOLaw & Business (JB&B), established in 1997, is the leading international publication established addressing critical topics impa cting the growth of the life sciences law, business, regulatory and policy sectors. Published quarterly, with topic-specific supplements and electronic updates, JB&B offers timely rep The Journal of BIOLaw & Business (JB&B) orting, thoughtful analysis, case studies and practical solutions in these emerg www.biolawbusiness.com ing fields. It is reading designed for those who want to stay ahead of rapidly changing innovations.

JB&B contributing editors, advisors and authors are world experts, providing “real world” perspectives, original analysis and practical tools for life science CEOs and senior executives, attorneys, biomedical researchers, entrepreneurs, licensing and tech transfer specialists, investors, policy-makers among others involved in this dynamic field.

The JB&B Collection consists of special thematic BioLaw & Business Supplements including: Bio-IP^TM, Bio-VC^TM, Bio-Informatics^TM and B israel-innovates.com io-Ethix^TM, among others. The JB&B International Series includes dedicated country-specific supplements focused on globalization in the life sciences with a focus on emerging trends in Australia, China, India, Israel, Singapor The Journal of Israel Innovation e and numerous other countries. The Journal of Israel Innovation and other customized publications are part of our portfolio. Electronic updates and notification of events are available to members of the BioLaw & Business Community through the BioLaw & Business News Service. On-line full text access is available to subscribers and member sites.

Each issue of JB&B examines a range of topics from an interdisciplinary perspective, reflective of the sectors’ nature. From emerging business models or regulatory and legal trends...to debates and advances in disruptive medical technology, stem cells, biogenerics, pricing policies, agbio, genomics and pharmaceutical research...to US and EU collaborations…JB&B reports on it all, and offers the rigorous thought and practical solutions you need to form effective legal, business, regulatory and policy responses.

By providing a "critical mass" of information so vital to professionals with an interest in 21st century life sciences, JB&B remains unparalleled, and in the forefront of a new era.